Exosomes vs Stem Cells
Two different materials from the same source tissue. One is a living cell; the other is the cell-free vesicle fraction that cell secretes.
Sourcing ComparisonResearch Use Only
What is the difference between exosomes and stem cells?
Mesenchymal stem cells are living, multipotent cells that can differentiate and self-renew; exosomes are the 40–150 nm extracellular vesicles those cells secrete, carrying mRNA, miRNA, proteins, and lipids with no nuclear material and no ability to replicate. Both of the materials Akira Biotech distributes come from the same source — Wharton's Jelly in donated umbilical cord tissue — so the decision between them is a decision about mechanism, handling, and characterization rather than about origin.
- A stem cell is the factory. It engrafts, responds to the local environment, differentiates along its lineage, and keeps secreting signalling factors for as long as it persists.
- An exosome is one shipment from that factory. Its cargo is fixed at the moment of manufacture, delivered once, and cannot adapt to the tissue it lands in.
- That trade is the whole comparison. Cells bring responsiveness and persistence; exosomes bring a cell-free, non-replicating, dose-countable product that is simpler to characterize and to ship.
Mechanism: differentiation and paracrine signalling vs cargo delivery
The literature describes three mechanisms for MSCs. Exosomes carry only the third.
Mesenchymal stem cells
- Direct differentiation into the lineage the product is specified for.
- Paracrine signalling — the cell secretes growth factors, cytokines, and its own exosomes in situ.
- Immunomodulation via IL-10 and TGF-β, regulating rather than suppressing the immune response.
- Low MHC class II expression, which is what makes allogeneic use without HLA matching possible.
Exosomes
- Cargo delivery only: mRNA, miRNA, proteins, and lipids released into recipient cells.
- No nucleus, no genome, and no capacity to self-replicate or differentiate.
- Formed by inward budding of endosomal multivesicular bodies, then released by the parent cell.
- Cargo profile is set by the parent lineage — which is why the catalog is organized by lineage.
Side by side
The specifications a purchasing decision actually turns on.
| Mesenchymal stem cells | Exosomes | |
|---|---|---|
| What it is | A living, multipotent cell | A 40–150 nm extracellular vesicle secreted by that cell |
| Nuclear material | Present — an intact nucleus and genome | None |
| Can it replicate? | Yes — self-renewal is the defining property | No |
| Primary mechanism | Direct differentiation plus paracrine signalling, immunomodulation, and homing | Cargo delivery only — mRNA, miRNA, proteins, and lipids into recipient cells |
| Immunogenicity | Low MHC class II expression; supplied allogeneic, no HLA matching | Cell-free, non-immunogenic; no surface MHC expression |
| Standard fills | 10 million / 2 mL and 25 million / 5 mL (base MSC also 5 million / 1 mL) | 400 billion+ per mL; 1.2 trillion+ per 3 mL on the high-dose SKUs |
| Cryopreservation | DMSO-free, glucose-based; animal-product-free media | Cell-free suspension; do not refreeze after thaw |
| Characterization on the COA | Immunophenotype (CD34−, CD45−, HLA-DR−), karyotype, post-thaw viability 98%+ | NTA-validated particle count, CD9⁺/CD63⁺/CD81⁺ identity markers, sterility |
| Routes as supplied | IV, IM, IA, IN, IT, SQ and site-directed, by lineage | IV, IM, IN, SQ, IA, topical and eye drops, by lineage |
| Lineages in the catalog | 19 products | 17 products |
The three cell-free tiers: exosomes, secretomes, Wharton's Jelly
If a protocol calls for something cell-free, there are three preparations to choose between, and they are frequently conflated.
| Preparation | What it contains | Positioning |
|---|---|---|
| Exosomes | The vesicular fraction only. | Most concentrated and most targeted cargo. 400 billion+ per mL. |
| Secretomes | The vesicular fraction plus the soluble fraction — proteins, cytokines, growth factors. | Broader paracrine signalling and more generalized functionality; 400+ proteins identified per batch by LC-MS/MS. |
| Wharton's Jelly | The whole tissue matrix, minimally processed — intact extracellular matrix with matrix-bound growth factors and trace resident cells. | The most complete preparation in the portfolio; matrix-driven rather than a cell-therapy product. |
Which one does a research program ask for?
Neither material is presented here as more effective than the other. These are the supply and handling considerations that usually decide it.
Programs that specify cells
- The protocol depends on engraftment, differentiation, or sustained in-situ signalling.
- The receiving site can hold cryopreserved material and handle a controlled thaw.
- Immunophenotype and karyotype are part of the release criteria being recorded.
Programs that specify exosomes
- A cell-free, non-replicating material is required by the study design or the jurisdiction.
- Dose needs to be expressed as a countable particle number rather than a cell count.
- The route is topical, intranasal, or otherwise poorly suited to a cell suspension.
Lineage coverage: matched cell and exosome products
Fourteen lineages are offered in both formats, so a program can switch between them without changing source tissue or supplier. The catalog holds 19 stem-cell products and 17 exosome products in total.
Also catalogued without a matched pair: dermal papilla exosomes, the tri-lineage AB Restore P/V formulation, isolated mitochondria, and secretomes.
Next steps
Every product is supplied by inquiry, with a certificate of analysis on every batch.
These are experimental use cases, provided as a scientific reference for researchers. Except where noted, they did not use Akira Biotech materials, and results may not be reproducible with ours. Akira Biotech supplies laboratory reagents for research use only. Our products are NOT approved by FDA or any regulatory authority and are not for use in or on humans.
Need Access to Full Product Information?
Our client portal provides detailed specifications, protocols, certificates of analysis, and streamlined ordering for qualified researchers and healthcare professionals.